Clinical Trials Browser

Melanoma × Muromonab-CD3 × Clear all

NCT00004022 2013-04-05

Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma

Phase 2 Completed

Melanoma

NCT00080353 2012-06-14

Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma

Phase 2 Completed

Melanoma